PT Kalbe Farma Tbk.
Simbolo: PTKFY
PNK
17.03
USDPrezzo di mercato oggi
0.0056
Rapporto P/E
0.0000
Rapporto PEG
3.94B
Capitalizzazione MRK
- 0.03%
Rendimento DIV
PT Kalbe Farma Tbk. (PTKFY) Bilanci finanziari
Stato patrimoniale
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3397916.9 | 263.9 | 455.6 | |||||
balance-sheet.row.short-term-investments | 0 | 165496.3 | 9.4 | 18.2 | |||||
balance-sheet.row.net-receivables | 0 | 5628331.7 | 308.5 | 249.4 | |||||
balance-sheet.row.inventory | 0 | 6791979.8 | 460 | 363.3 | |||||
balance-sheet.row.other-current-assets | 0 | 99495.7 | 44.4 | 37.2 | |||||
balance-sheet.row.total-current-assets | 0 | 15917724.1 | 1076.8 | 1105.6 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 8537934.7 | 535.8 | 586.3 | |||||
balance-sheet.row.goodwill | 0 | 479347.4 | 30.9 | 14.8 | |||||
balance-sheet.row.intangible-assets | 0 | 1327234.2 | 1066868.8 | 961154.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1806581.6 | 1546216.2 | 1170837.9 | |||||
balance-sheet.row.long-term-investments | 0 | 285302.3 | 24.8 | 21.3 | |||||
balance-sheet.row.tax-assets | 0 | 136102.6 | 8.2 | 6.5 | |||||
balance-sheet.row.other-non-current-assets | 0 | 373922.8 | -1546106.4 | -1170751.6 | |||||
balance-sheet.row.total-non-current-assets | 0 | 11139844.1 | 678.6 | 700.4 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.account-payables | 0 | 1690719.6 | 128.7 | 117.3 | |||||
balance-sheet.row.short-term-debt | 0 | 299759.4 | 55.1 | 6.6 | |||||
balance-sheet.row.tax-payables | 0 | 225196.6 | 13.8 | 19 | |||||
balance-sheet.row.long-term-debt-total | 0 | 318778.9 | 18.5 | 34.5 | |||||
Deferred Revenue Non Current | 0 | 0 | 1.6 | 3 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 1252689.5 | 87.9 | 105.7 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 694377.6 | 45.9 | 60.9 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 41907.5 | 1.6 | 3 | |||||
balance-sheet.row.total-liab | 0 | 3937546.2 | 331.5 | 309.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 468751.2 | 30.2 | 33 | |||||
balance-sheet.row.retained-earnings | 0 | 21162752.5 | 1300.8 | 1299.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 53.5 | 49.4 | 47.7 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | -212700.7 | -66.9 | -2.5 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 21418856.5 | 1313.6 | 1377.7 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.minority-interest | 0 | 1701165.5 | 110.3 | 118.7 | |||||
balance-sheet.row.total-equity | 0 | 23120022 | 1423.9 | 1496.3 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 450798.6 | 34.1 | 39.6 | |||||
balance-sheet.row.total-debt | 0 | 618538.4 | 75.2 | 44.1 | |||||
balance-sheet.row.net-debt | 0 | -2613882.2 | -179.3 | -393.3 |
Rendiconto finanziario
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 181.1 | 228.4 | 222.4 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.4 | 47.1 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-non-cash-items | 0 | -35.9 | -191.1 | -68.6 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.acquisitions-net | 0 | 63609.6 | -44.9 | 82.8 | |||||
cash-flows.row.purchases-of-investments | 0 | -173704.2 | -8.6 | -17.5 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 4.7 | 16.7 | 8.5 | |||||
cash-flows.row.other-investing-activites | 0 | 148275.5 | -0.3 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1140786.7 | -95.9 | 3.8 | |||||
cash-flows.row.debt-repayment | 0 | -2513595.4 | -24.2 | -35.4 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | -2.6 | 0 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -67.7 | 0 | |||||
cash-flows.row.dividends-paid | 0 | -1757714.4 | -110.2 | -91.7 | |||||
cash-flows.row.other-financing-activites | 0 | 35572 | 44.6 | -6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2443986.3 | -160 | -133.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -40050.4 | 237776.4 | -16432.5 | |||||
cash-flows.row.net-change-in-cash | 0 | -717348.3 | -182.9 | 65.7 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 3232420.6 | 254.5 | 437.4 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3949768.9 | 437.4 | 371.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 193.1 | 86.8 | 200.9 | |||||
cash-flows.row.capital-expenditure | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.free-cash-flow | 0 | -1178779.2 | 28 | 131 |
Riga del conto economico
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 30449134.1 | 1953.9 | 1834.5 | |||||
income-statement-row.row.cost-of-revenue | 0 | 18625888.5 | 1189.7 | 1073.3 | |||||
income-statement-row.row.gross-profit | 0 | 11823245.5 | 764.2 | 761.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.operating-expenses | 0 | 8198108.5 | 481.4 | 483.3 | |||||
income-statement-row.row.cost-and-expenses | 0 | 26823997 | 1671.1 | 1556.5 | |||||
income-statement-row.row.interest-income | 0 | 88217.6 | 5.5 | 7.7 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.total-operating-expenses | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 333650.2 | 49.4 | 47.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 3672252.6 | 282.8 | 277.9 | |||||
income-statement-row.row.income-before-tax | 0 | 3606237.2 | 301.1 | 289.4 | |||||
income-statement-row.row.income-tax-expense | 0 | 827832.4 | 68.1 | 63.7 | |||||
income-statement-row.row.net-income | 0 | 2766748 | 228.4 | 222.4 |
Domande frequenti
Che cos'è PT Kalbe Farma Tbk. (PTKFY) totale attivo?
PT Kalbe Farma Tbk. (PTKFY) il totale delle attività è 27057568182323.000.
Qual è il fatturato annuo dell'impresa?
Il fatturato annuo è N/A.
Qual è il margine di profitto dell'azienda?
Il margine di profitto dell'azienda è 0.370.
Qual è il flusso di cassa libero dell'azienda?
Il flusso di cassa libero è -1793.009.
Qual è il margine di profitto netto dell'impresa?
Il margine di profitto netto è 0.089.
Qual è il fatturato totale dell'azienda?
Le entrate totali sono 0.123.
Che cos'è il PT Kalbe Farma Tbk. (PTKFY) utile netto (reddito netto)?
L'utile netto (reddito netto) è 2766748040055.000.
Qual è il debito totale dell'azienda?
Il debito totale è 618538351178.000.
Qual è il numero di spese operative?
Le spese operative sono 8198108504360.000.
Qual è la cifra della liquidità aziendale?
La liquidità aziendale è 0.000.